Murray D. Mitchell, D.Phil, D.Sc, FRSNZ, is Professor and immediate past Director, UQ Centre for Clinical Research. Previously he was Research Director and Deputy Director of the newly established Liggins Institute at the University of Auckland and Deputy Director of the National Research Centre for Growth and Development. He has held positions at the Universities of Oxford, Southwestern Medical School in Dallas, University of California, San Diego, University of Utah and latterly was Head of the Department of Pharmacology and then Associate Dean of Planning and Deputy Dean the University of Auckland, Faculty of Medical and Health Sciences. He has a D.Sc from Liverpool University and a D.Phil from Oxford University.
Professor Mitchell has received many distinctions including : Staines Medical Research Fellow, Exeter College, Oxford University; 1988 Junior Research Fellow, Wolfson College, Oxford University; Presidents Achievement Award, Society for Gynecologic Investigation; NZ President Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists; Fellowship of the Royal Society of New Zealand (FRSNZ) and a James Cook Research Fellowship of RSNZ. He was elected to Fellowship ad eundem of The Royal College of Obstetricians and Gynaecologists in 2015 and in 2016 was elected President Nominee of The Society for Reproductive Investigation to be President in 2019 for the next International Annual Meeting of the Society in Paris.
His research interests are based broadly on the biochemical mechanisms of growth and differentiation of tissues at the molecular, cellular, organ and whole animal level. Attention is focused on the development of fetal tissues and uterine tissues that play a part in the mechanism(s) of parturition. In particular, the causes and consequences of preterm birth and intrauterine growth restriction are being studied in order to evaluate the potential effects on early development and later vulnerability to disease in adulthood and in subsequent generations of offspring. The factors under investigation range from the iatrogenic to environmental agents such as bisphenol A to maternal nutritional status at differing times.